This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG0L1BN_L.jpg(Reuters) – Abbott Laboratories Inc (N:) reported a 60% rise in fourth-quarter profit on Wednesday, boosted by strong sales of its diabetes and heart devices.
The company’s net earnings rose to $1.05 billion, or 59 cents per share, in the quarter ended Dec. 31, from $654 million, or 37 cents per share, a year earlier.
Net sales of the medical device maker rose 7% to $8.31 billion.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.